Replimune Group, Inc. (REPL)
19.89
+0.40
(+2.05%)
USD |
NASDAQ |
Nov 03, 11:42
Replimune Group Price : 19.89 for Nov. 3, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 17.75 | 19.68 | 17.67 | 19.49 | 7.725M |
| Oct 30, 2026 | 17.49 | 18.27 | 16.64 | 17.61 | 3.854M |
| Oct 29, 2026 | 16.27 | 17.78 | 16.20 | 17.39 | 5.146M |
| Oct 28, 2026 | 12.96 | 16.75 | 12.50 | 16.06 | 7.285M |
| Oct 27, 2026 | 12.45 | 13.16 | 12.21 | 13.05 | 4.298M |
| Oct 26, 2026 | 11.56 | 12.57 | 11.36 | 12.47 | 2.046M |
| Oct 23, 2026 | 11.92 | 11.92 | 11.43 | 11.46 | 1.905M |
| Oct 22, 2026 | 11.70 | 12.01 | 11.53 | 11.99 | 1.761M |
| Oct 21, 2026 | 11.37 | 12.04 | 11.31 | 11.72 | 2.202M |
| Oct 20, 2026 | 11.04 | 11.69 | 11.00 | 11.42 | 1.389M |
| Oct 19, 2026 | 11.03 | 11.22 | 10.67 | 11.05 | 1.540M |
| Oct 16, 2026 | 11.73 | 11.73 | 10.80 | 10.86 | 1.712M |
| Oct 15, 2026 | 11.32 | 11.86 | 11.23 | 11.75 | 1.614M |
| Oct 14, 2026 | 12.05 | 12.37 | 11.37 | 11.39 | 1.864M |
| Oct 13, 2026 | 12.91 | 12.93 | 12.07 | 12.11 | 1.632M |
| Oct 12, 2026 | 13.21 | 13.56 | 12.97 | 13.07 | 1.161M |
| Oct 09, 2026 | 12.96 | 13.44 | 12.79 | 13.42 | 2.023M |
| Oct 08, 2026 | 13.18 | 13.46 | 12.85 | 13.04 | 1.748M |
| Oct 07, 2026 | 13.14 | 13.60 | 13.01 | 13.20 | 1.647M |
| Oct 06, 2026 | 13.17 | 13.51 | 12.87 | 13.25 | 2.618M |
| Oct 05, 2026 | 13.14 | 13.29 | 12.51 | 13.15 | 2.276M |
| Oct 02, 2026 | 13.69 | 13.83 | 12.80 | 13.07 | 1.303M |
| Oct 01, 2026 | 13.26 | 13.59 | 13.06 | 13.45 | 2.519M |
| Sep 30, 2026 | 12.99 | 13.66 | 12.65 | 13.24 | 3.082M |
| Sep 29, 2026 | 12.44 | 13.42 | 12.35 | 13.00 | 4.365M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Kalaris Therapeutics, Inc. | 2.12 |
| Arrowhead Pharmaceuticals, Inc. | 60.06 |
| Oncolytics Biotech, Inc. | 0.3951 |
| Sangamo Therapeutics, Inc. | 0.115 |
| Sarepta Therapeutics, Inc. | 18.60 |
Price Related Metrics
| Price to Book Value | 9.208 |
| Earnings Yield | -14.67% |
| Market Cap | 1.886B |